Literature DB >> 3001803

Cholinergic modulation of memory in rats.

V Haroutunian, E Barnes, K L Davis.   

Abstract

Central cholinergic systems have long been implicated in the modulation of learning and memory processes in animals and man. Drugs that affect the central cholinergic system have been found either to enhance or to hinder performance in tests of learning and memory. Few studies have evaluated the effects of different cholinergic drugs within a single experimental paradigm and with a relatively wide dose range. The studies reported here investigated the effects of cholinergic drugs with diverse modes of action on the retention of a passive avoidance response. Physostigmine, arecoline, oxotremorine, nicotine, and 4-aminopyridine were administered IP immediately following the acquisition of a one-trial passive avoidance task. All of the drugs were found to enhance 72-h retention of passive avoidance; however, the effective doses were different for each of the drugs studied.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001803     DOI: 10.1007/bf00432705

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals.

Authors:  H Lundh; S Thesleff
Journal:  Eur J Pharmacol       Date:  1977-04-21       Impact factor: 4.432

Review 2.  Pharmacological implications of brain acetylcholine turnover measurements in rat brain nuclei.

Authors:  D L Cheney; E Costa
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

3.  POST-TRIAL INJECTIONS OF AN ANTI-CHOLINESTERASE DRUG AND MAZE LEARNING IN TWO STRAINS OF RATS.

Authors:  L O STRATTON; L PETRINOVICH
Journal:  Psychopharmacologia       Date:  1963-10-24

4.  4-aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome.

Authors:  H Lundh; O Nilsson; I Rosén
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-11       Impact factor: 10.154

5.  Consolidation and maze learning: a study of some strain-drug interactions.

Authors:  M Garg; H C Holland
Journal:  Psychopharmacologia       Date:  1969

6.  Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes.

Authors:  E K Perry; G Blessed; B E Tomlinson; R H Perry; T J Crow; A J Cross; G J Dockray; R Dimaline; A Arregui
Journal:  Neurobiol Aging       Date:  1981       Impact factor: 4.673

Review 7.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

8.  Pharmacological alleviation of cholinergic lesion induced memory deficits in rats.

Authors:  V Haroutunian; P Kanof; K L Davis
Journal:  Life Sci       Date:  1985-09-09       Impact factor: 5.037

9.  Cholinergic receptor interactions and their effects on long-term memory processing.

Authors:  J F Flood; D W Landry; M E Jarvik
Journal:  Brain Res       Date:  1981-06-29       Impact factor: 3.252

10.  Stimulation of phrenic nerve activity by an acetylcholine releasing drug: 4-aminopyridine.

Authors:  H Folgering; J Rutten; S Agoston
Journal:  Pflugers Arch       Date:  1979-03-16       Impact factor: 3.657

View more
  24 in total

1.  Low-dose nicotine facilitates spatial memory in ApoE-knockout mice in the radial arm maze.

Authors:  Ruby Sultana; Kiyoshi Ameno; Mostofa Jamal; Takanori Miki; Naoko Tanaka; Junichiro Ono; Hiroshi Kinoshita; Yu Nakamura
Journal:  Neurol Sci       Date:  2012-07-07       Impact factor: 3.307

2.  Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.

Authors:  N Yamazaki; K Kato; E Kurihara; A Nagaoka
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 3.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats.

Authors:  M W Decker; M J Majchrzak
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Memory modulation with peripherally acting cholinergic drugs.

Authors:  D K Rush; K Streit
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats.

Authors:  A C Santucci; P D Kanof; V Haroutunian
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 7.  Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.

Authors:  B P Imbimbo
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

8.  Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats.

Authors:  J Mastropaolo; N S Nadi; N L Ostrowski; J N Crawley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats.

Authors:  J Turchi; L A Holley; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

10.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.